Resonance Specialities Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 995985, "name": "Resonance Speci.", "stock_name": "Resonance Speci.", "full_name": "Resonance Specialities Ltd", "name_url": "stocks-analysis/resonance-speci", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "109.00", "chg": 1.25, "chgp": "1.16%", "dir": 1, "prev_price": "107.75", "mcapval": "127.00 Cr", "mcap": "Micro Cap", "scripcode": 524218, "symbol": "", "ind_name": "Specialty Chemicals", "ind_code": 11, "indexname": "", "isin": "INE486D01017", "curr_date": "Feb 09", "curr_time": "", "bse_nse_vol": "17.15 k", "exc_status": "Active", "traded_date": "Feb 09, 2026", "traded_date_str": "2026 02 09", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/resonance-speci-995985-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Resonance Specialities Ltd: 0.09% Dip Amid Valuation Shift and Q3 Profit Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/resonance-specialities-ltd-009-dip-amid-valuation-shift-and-q3-profit-surge-3826145", "imagepath": "", "date": "2026-02-07 13:06:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Feb 2:</strong> Stock opens at Rs.106.70, declines 1.07% amid broader market weakness</p>\n <p><strong>Feb 3:</strong> Sharp rebound with 4.12% gain following positive market sentiment</p>\n <p><strong>Feb 4:</strong> Q3 FY26 results announced, strong profit growth lifts stock 3.87%</p>\n <p><strong>Feb 5:</strong> Profit-taking leads to 6.24% drop despite stable Sensex</p>\n <p><strong>Feb 6:</strong> Valuation grade shifts to fair; stock closes slightly down at Rs.107.75 (-0.42%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-la..." }, { "title": "Resonance Specialities Ltd Valuation Shifts to Fair; P/E and P/BV Reflect Improved Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/resonance-specialities-ltd-valuation-shifts-to-fair-pe-and-pbv-reflect-improved-price-attractiveness-3823610", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ResonanceSpecia_valuationdot_3823610.png", "date": "2026-02-06 08:01:46", "description": "Resonance Specialities Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling improved price attractiveness for investors. This change is underscored by a significant moderation in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical levels and peer benchmarks within the specialty chemicals sector." }, { "title": "Are Resonance Specialities Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-resonance-specialities-ltd-latest-results-good-or-bad-3822914", "imagepath": "", "date": "2026-02-05 19:27:25", "description": "Resonance Specialities Ltd has reported notable financial results for the quarter ended December 2025. The company achieved net sales of ₹22.96 crores, reflecting a year-on-year growth of 25.88% compared to ₹18.24 crores in the same quarter last year. This growth indicates a positive trend in demand and operational performance, as the company also saw a sequential revenue increase of 6.64% from ₹21.53 crores in the previous quarter.\n\nThe net profit for the same quarter reached ₹2.51 crores, marking a significant year-on-year increase of 124.10% from ₹1.12 crores in the corresponding quarter last year. This substantial rise in profitability underscores the company's operational improvements and effective cost management strategies.\n\nOperating margins have also shown a positive trajectory, with the operating margin standing at 15.03%, an increase of 467 basis points compared to 10.36% in the previous year. Th..." }, { "title": "Resonance Specialities Q3 FY26: Strong Profit Growth Drives Momentum Despite Margin Volatility", "link": "https://www.marketsmojo.com/news/result-analysis/resonance-specialities-q3-fy26-strong-profit-growth-drives-momentum-despite-margin-volatility-3821090", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ResonanceSpecia_quaterlyResult_3821090.png", "date": "2026-02-04 18:02:27", "description": "Resonance Specialities Limited, a Mumbai-based manufacturer of pyridine and pyridine derivatives, reported robust profit growth in Q3 FY26, with net profit surging 124.10% year-on-year to ₹2.51 crores. The micro-cap specialty chemicals company, with a market capitalisation of ₹128 crores, witnessed its stock rally 3.51% to ₹115 following the results announcement, reflecting investor enthusiasm about the improved profitability trajectory." }, { "title": "Resonance Specialities Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/resonance-specialities-ltd-is-rated-hold-3817765", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ResonanceSpecia_mojoScore_3817765.png", "date": "2026-02-03 10:14:03", "description": "Resonance Specialities Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook." }, { "title": "Resonance Specialities Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/resonance-specialities-ltd-is-rated-sell-3801429", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ResonanceSpecia_mojoScore_3801429.png", "date": "2026-01-23 10:10:54", "description": "Resonance Specialities Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 23 January 2026, providing investors with the most up-to-date analysis." }, { "title": "Resonance Specialities Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/resonance-specialities-ltd-is-rated-hold-3789788", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ResonanceSpecia_mojoScore_3789788.png", "date": "2026-01-12 10:10:21", "description": "Resonance Specialities Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 December 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 January 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Resonance Specialities Ltd Upgraded to Hold on Improved Technicals and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/resonance-specialities-ltd-upgraded-to-hold-on-improved-technicals-and-financial-trends-3777115", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ResonanceSpecia_mojoScore_3777115.png", "date": "2026-01-01 08:12:42", "description": "Resonance Specialities Ltd has seen its investment rating upgraded from Sell to Hold as of 31 Dec 2025, reflecting a combination of improved technical indicators, steady financial performance, and a more balanced valuation. The specialty chemicals company’s recent quarterly results and evolving market trends have contributed to a more optimistic outlook, despite some lingering concerns over long-term growth." }, { "title": "Resonance Specialities: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/resonance-specialities-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3772708", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ResonanceSpecia_mojoScore_3772708.png", "date": "2025-12-29 08:10:41", "description": "Resonance Specialities, a key player in the specialty chemicals sector, has experienced a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s evaluation metrics, providing investors with a comprehensive understanding of its current standing." } ], "total": 156, "sid": "995985", "stock_news_url": "https://www.marketsmojo.com/news/resonance-specialities-995985" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Cessation", "datetime": "06-Feb-2026", "details": "Completion of tenure of Mrs. Archana Yadav (Din: 07335198) as an Independent Director of the Company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "05-Feb-2026", "details": "Unaudited Financial results for 3rd quarter and 9 months ended December 31 2025 published in newspaper.", "source": "BSE" }, { "caption": "UNAUDITED FINANCIAL RESULTS FOR Q3 AND 9 MONTHS ENDED DECEMBER 31 2025", "datetime": "04-Feb-2026", "details": "UNAUDITED FINANCIAL RESULTS FOR Q3 AND 9 MONTHS ENDED DECEMBER 31 2025.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Resonance Specialities Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Jul 25", "dt": "2025-07-29", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Feb 2: Stock opens at Rs.106.70, declines 1.07% amid broader market weakness

Feb 3: Sharp rebound with 4.12% gain following positive market sentiment

Feb 4: Q3 FY26 results announced, strong profit growth lifts stock 3.87%

Feb 5: Profit-taking leads to 6.24% drop despite stable Sensex

Feb 6: Valuation grade shifts to fair; stock closes slightly down at Rs.107.75 (-0.42%)

Read full news article

Resonance Specialities Ltd Valuation Shifts to Fair; P/E and P/BV Reflect Improved Price Attractiveness

2026-02-06 08:01:46

Resonance Specialities Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling improved price attractiveness for investors. This change is underscored by a significant moderation in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical levels and peer benchmarks within the specialty chemicals sector.

Read full news article

Are Resonance Specialities Ltd latest results good or bad?

2026-02-05 19:27:25

Resonance Specialities Ltd has reported notable financial results for the quarter ended December 2025. The company achieved net sales of ₹22.96 crores, reflecting a year-on-year growth of 25.88% compared to ₹18.24 crores in the same quarter last year. This growth indicates a positive trend in demand and operational performance, as the company also saw a sequential revenue increase of 6.64% from ₹21.53 crores in the previous quarter. The net profit for the same quarter reached ₹2.51 crores, marking a significant year-on-year increase of 124.10% from ₹1.12 crores in the corresponding quarter last year. This substantial rise in profitability underscores the company's operational improvements and effective cost management strategies. Operating margins have also shown a positive trajectory, with the operating margin standing at 15.03%, an increase of 467 basis points compared to 10.36% in the previous year. Th...

Read full news article

Resonance Specialities Q3 FY26: Strong Profit Growth Drives Momentum Despite Margin Volatility

2026-02-04 18:02:27

Resonance Specialities Limited, a Mumbai-based manufacturer of pyridine and pyridine derivatives, reported robust profit growth in Q3 FY26, with net profit surging 124.10% year-on-year to ₹2.51 crores. The micro-cap specialty chemicals company, with a market capitalisation of ₹128 crores, witnessed its stock rally 3.51% to ₹115 following the results announcement, reflecting investor enthusiasm about the improved profitability trajectory.

Read full news article

Resonance Specialities Ltd is Rated Hold

2026-02-03 10:14:03

Resonance Specialities Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 February 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook.

Read full news article

Resonance Specialities Ltd is Rated Sell

2026-01-23 10:10:54

Resonance Specialities Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 23 January 2026, providing investors with the most up-to-date analysis.

Read full news article

Resonance Specialities Ltd is Rated Hold

2026-01-12 10:10:21

Resonance Specialities Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 December 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Resonance Specialities Ltd Upgraded to Hold on Improved Technicals and Financial Trends

2026-01-01 08:12:42

Resonance Specialities Ltd has seen its investment rating upgraded from Sell to Hold as of 31 Dec 2025, reflecting a combination of improved technical indicators, steady financial performance, and a more balanced valuation. The specialty chemicals company’s recent quarterly results and evolving market trends have contributed to a more optimistic outlook, despite some lingering concerns over long-term growth.

Read full news article

Resonance Specialities: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-29 08:10:41

Resonance Specialities, a key player in the specialty chemicals sector, has experienced a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent changes in the company’s evaluation metrics, providing investors with a comprehensive understanding of its current standing.

Read full news article